Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4597718016 | Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4597719012 | Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Topical abrasive agents | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Benzalkonium chloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Polyethylene | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Topical abrasive agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Topical anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing benzalkonium in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Conventional release cutaneous gel | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing polymer | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing only benzalkonium and polyethylene in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance | Polyethylene | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Polyethylene | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance | Benzalkonium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Benzalkonium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 219 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Polyethylene+benzalkonium chloride 21.9/0.25% gel - product | Is a | False | Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR